Alpha-synuclein pathology is highly dependent on the case selection
- PMID: 11532162
- DOI: 10.1046/j.0305-1846.2001.00342.x
Alpha-synuclein pathology is highly dependent on the case selection
Abstract
Lewy bodies and dystrophic neurites have been considered a common substrate for dementia, but they are also frequently found in the normal elderly population. The primary component of this pathology involves alpha-synuclein. The main objective of the present study was to estimate the prevalence of alpha-synuclein pathology in aged population, and to assess its relative significance in relation to dementia. The study also investigated whether differences could be detected in alpha-synuclein pathology in relation to age, gender or concomitant Alzheimer's pathology. Furthermore, the influence of sampling strategies was analysed. Alpha-synuclein pathology was assessed using immunohistochemistry in well-characterized post-mortem material. The investigation included patients from a longitudinal study of dementia of Alzheimer's type (n = 103, 85% demented), subjects from a prospective longitudinal clinical study of ageing (n = 69, 29% demented), a cohort of consecutive clinical post-mortem cases collected for 1 year (n = 262, 12% demented), a sample of forensic post-mortem cases collected for 6 months (n = 121, 15% demented) and a sample of Brain Bank material (n = 234, 26% demented). Overall, alpha-synuclein pathology was found in 14% of all 774 subjects over 40 years of age, and this percentage varied from 8% to 27% according to sampling strategies. These results indicate that the prevalence of alpha-synuclein pathology clearly depends on the selection of material. Furthermore alpha-synuclein pathology was found in 23% of clinically demented patients and in 11% of non-demented subjects. The load of alpha-synuclein pathology was significantly greater in the demented patients versus non-demented subjects indicating that alpha-synuclein pathology is indeed of importance in the pathogenesis of dementia.
Similar articles
-
Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease.Neurology. 2000 May 23;54(10):1916-21. doi: 10.1212/wnl.54.10.1916. Neurology. 2000. PMID: 10822429
-
Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study.Acta Neuropathol. 2003 Oct;106(4):374-82. doi: 10.1007/s00401-003-0750-x. Epub 2003 Aug 2. Acta Neuropathol. 2003. PMID: 12904992
-
Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.Acta Neuropathol. 2003 Sep;106(3):191-201. doi: 10.1007/s00401-003-0725-y. Epub 2003 Jul 5. Acta Neuropathol. 2003. PMID: 12845452
-
[Recent advances in the neuropathological evaluation of Alzheimer's disease: the importance of alpha-synuclein].Rev Neurol. 2002 Oct 16-31;35(8):765-7. Rev Neurol. 2002. PMID: 12402231 Review. Spanish.
-
The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.Ann N Y Acad Sci. 2000;920:16-27. doi: 10.1111/j.1749-6632.2000.tb06900.x. Ann N Y Acad Sci. 2000. PMID: 11193145 Review.
Cited by
-
Clinical effects of Lewy body pathology in cognitively impaired individuals.Nat Med. 2023 Aug;29(8):1964-1970. doi: 10.1038/s41591-023-02449-7. Epub 2023 Jul 18. Nat Med. 2023. PMID: 37464058 Free PMC article.
-
Characterizing Lewy Pathology in 231 Essential Tremor Brains From the Essential Tremor Centralized Brain Repository.J Neuropathol Exp Neurol. 2022 Sep 19;81(10):796-806. doi: 10.1093/jnen/nlac068. J Neuropathol Exp Neurol. 2022. PMID: 35950950 Free PMC article.
-
An update on essential tremor.Curr Neurol Neurosci Rep. 2009 Jul;9(4):273-7. doi: 10.1007/s11910-009-0041-6. Curr Neurol Neurosci Rep. 2009. PMID: 19515278 Review.
-
Lewy body pathology in normal elderly subjects.J Neuropathol Exp Neurol. 2009 Jul;68(7):816-22. doi: 10.1097/NEN.0b013e3181ac10a7. J Neuropathol Exp Neurol. 2009. PMID: 19535990 Free PMC article.
-
Practical use of DAT SPECT imaging in diagnosing dementia with Lewy bodies: a US perspective of current guidelines and future directions.Front Neurol. 2024 Apr 22;15:1395413. doi: 10.3389/fneur.2024.1395413. eCollection 2024. Front Neurol. 2024. PMID: 38711561 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous